Low dose AKT inhibitor miransertib cures PI3K-related vascular malformations in preclinical models of human disease

Piotr Kobialka(Josep Carreras Leukaemia Research Institute), Mariona Graupera(Instituto de Salud Carlos III)
bioRxiv (Cold Spring Harbor Laboratory)
July 16, 2021
Cited by 6


Related Papers